| NCT Number | NCT07541469 |
| Lead Sponsor | Madrigal Pharmaceuticals, Inc. |
| Conditions | MASH - Metabolic Dysfunction-Associated Steatohepatitis |
| Enrollment | 10 participants |
| Start Date | 2026-03-04 |
| Primary Completion | 2030-04-08 (estimated) |
| Study Completion | 2030-04-08 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-21 |